SCHOTT InauguratesNew Production for Pharmaceutical Packaging in Russia
First international manufacturer in Russia
Nizhny Novgorod (Russia) / Mainz,May 24,2011 –
International technology group SCHOTT today officially inaugurated a production site for primary pharmaceutical packaging located in Zavolzhe, near the Russian city of Nizhny Novgorod. The new production site will employ around 60 employees initially and will produce premium quality ampoules and vials. SCHOTT plans to increase the number of employees up to over 200 in the mid-term. “We are the first international group, which manufactures primary pharmaceutical packaging made of glass, to open a production facility in Russia. With this new plant, we are further expanding our position as the leading supplier to the pharmaceutical industry in Russia,” said Professor Dr. Udo Ungeheuer, Chairman of the Management Board of SCHOTT AG, at the plant inauguration in Zavolzhe.
SCHOTT Pharmaceutical Systems is one of the world’s leading suppliers of glass tubing and primary packaging for the pharmaceutical industry. With its packaging expertise and quality commitment, SCHOTT will support Russian pharmaceutical companies in meeting the requirements of „Pharma 2020“. The company has been selling ampoules, vials, cartridges and syringes to the Russian market already since the beginning of the 1990s. So far, Russian customers have been mainly supplied from the existing pharmaceutical packaging site in Hungary.
With new business operations in major growth markets such as China and Argentina, SCHOTT has continuously expanded its global network of pharmaceutical packaging production plants in recent years. Furthermore, SCHOTT has formed a joint venture with Japanese company Naigai Glass Industry Co., Ltd. at the end of 2010 in order to strengthen its position in Japan, the world’s second largest pharmaceutical market. With more than 600 production lines in 14 countries around the world, SCHOTT manufactures over seven billion syringes, vials, ampoules, cartridges, and special products for the pharmaceutical industry each year. All products are manufactured according to cGMP guidelines (current Good Manufacturing Practices) and meet the high international standards for primary pharmaceutical packaging.
„With our new facility in Zavolzhe, we are able to satisfy local demands even better than before,” said Dr. Juergen Sackhoff, Executive Vice President of SCHOTT Pharmaceutical Systems.
The new plant for primary pharmaceutical packaging is SCHOTT’s second production site in Russia. The company already runs a flat glass processing plant in Bor, near the city of Nizhny Novgorod, that supplies the household appliance industry. Furthermore, SCHOTT established a delegate office in Moscow, the Russian capital, in 1995.
Number of characters:x.xxx
About SCHOTT Pharmaceutical Systems
SCHOTT Pharmaceutical Systems is one of the world’s leading suppliers of glass tubingand primary packaging for the pharmaceutical industry. We provide our customers qualitysolutions while meeting their highest demands with our material expertise, specialized analyticallab services, and a broad product portfolio; including, syringes, cartridges, vials, ampoules,and special articles made of glass and COC polymer. With four glass tubing productionsites and fifteen sites for pharmaceutical packaging spread over four continents, weoffer safe supply and local service. Our state-of-the-art production facilities and our productscomply with the highest international quality standards for pharmaceutical needs.
About SCHOTT
SCHOTT is an international technology group with more than 125 years of experience in the areas of specialty glasses and materials and advanced technologies. SCHOTT ranks number one in the world with many of its products. Its core markets are the household appliance, solar power, pharmaceuticals, electronics, optics, transportation and architecture industries. The company is strongly committed to contributing to its customers’ success and making SCHOTT an important part of people’s lives with high-quality products and intelligent solutions. SCHOTT is committed to managing its business in a sustainable manner and supporting its employees, society and the environment. The SCHOTT Group maintains close proximity to its customers with manufacturing and sales units in all major markets. Its workforce of around 17,500 employees generated worldwide sales of approximately 2.9 billion Euros for the 2009/2010 fiscal year. SCHOTT AG, with its headquarters in Mainz (Germany) is owned by the Carl Zeiss Foundation.
Contact:
SCHOTT AG
Klaus Bernhard Hofmann
Chief Press Officer
Phone:+49 (0) 6131 / 66-3662
Fax: +49 (0) 3641 / 2888-9140
E-Mail:
Internet:
SCHOTT forma vitrum ag
Christa Fritschi
Director Marketing
Phone: +41 (0) 71 274-1602
E-Mail:
Internet:
PI No.:069_2011
Page1of3